Evidence map›Paper›PMID 34179724›Full record

ArticleAnimal models and experimental medicine2021

Novel spontaneous myelodysplastic syndrome mouse model.

Weisha Li, Lin Cao, Mengyuan Li, Xingjiu Yang, Wenlong Zhang, Zhiqi Song, Xinpei Wang, Lingyan Zhang, Grant Morahan, Chuan Qin and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Animal models and experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Humanized mouse models in MDS.Cell death & disease · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Novel spontaneous myelodysplastic syndrome mouse model.Animal models and experimental medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Weisha LiNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.ORCID 0000-0002-1370-6067
Lin CaoNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Mengyuan LiNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Xingjiu YangNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Wenlong ZhangNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Zhiqi SongNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Xinpei WangNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Lingyan ZhangNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Grant MorahanNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Chuan QinNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Ran GaoNHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center Peking Union Medical College (PUMC) Beijing China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Myelodysplastic syndrome (MDS) is a group of disorders involving hemopoietic dysfunction leading to leukemia. Although recently progress has been made in identifying underlying genetic mutations, many questions still remain. Animal models of MDS have been produced by introduction of specific mutations. However, there is no spontaneous mouse model of MDS, and an animal model to simulate natural MDS pathogenesis is urgently needed. Methods: In characterizing the genetically diverse mouse strains of the Collaborative Cross (CC) we observed that one, designated JUN, had abnormal hematological traits. This strain was thus further analyzed for phenotypic and pathological identification, comparing the changes in each cell population in peripheral blood and in bone marrow. Results: In a specific-pathogen free environment, mice of the JUN strain are relatively thin, with healthy appearance. However, in a conventional environment, they become lethargic, develop wrinkled yellow hair, have loose and light stools, and are prone to infections. We found that the mice were cytopenic, which was due to abnormal differentiation of multipotent bone marrow progenitor cells. These are common characteristics of MDS. Conclusions: A mouse strain, JUN, was found displaying spontaneous myelodysplastic syndrome. This strain has the advantage over existing models in that it develops MDS spontaneously and is more similar to human MDS than genetically modified mouse models. JUN mice will be an important tool for pathogenesis research of MDS and for evaluation of new drugs and treatments.

Indexed as

AnemiaLeukopeniaMyelodysplastic SyndromesAnimalsBone MarrowDisease Models, AnimalMicemyelodysplastic syndrome (MDS)spontaneous mouse modelThe Collaborative Cross Mice

Identifiers

PMID34179724
PMCPMC8212821
OpenAlexW3161290815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.